Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

Lauzon 2015_06 Current Topics in Life Sciences Law Regulation and Business

Current Topics in Life Sciences Law, Regulation and Business hosted by Center for Law and Entrepreneurship at Villanova University School of Law | News & Events | Goodwin

Current Topics in Life Sciences Law, Regulation and Business hosted by Center for Law and Entrepreneurship at Villanova University School of Law

Summary

Speakers

Danielle M. Lauzon

Elaine Herrmann Blais

Duncan A. Greenhalgh

Related Content

Four Steps to Maximize the Value of AI Innovation in Medtech

The Rapid Rise of AI, in Five Charts

What’s Next for AI? Six Areas to Watch in 2024

The Unified Patent Court is (Finally) Coming to Europe and Bringing Some Pretty Fundamental Changes with It

A Primer On Patenting Ranges

Five Tips For Life Sciences Companies To Protect Their AI Technologies

Aren’t You Glad 2020 Is Over? A Look Back (and Ahead)

Strategic Considerations for Seeking Patent Term Extension (PTE) and its Scope for Drug Products

US & EP Data Exclusivity: Same Name, Different Games

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 186 Lawyers

IAM Patent 1000 2024 Recognizes Goodwin for Patent Law Excellence

Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service

Chambers Global 2024 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year

Managing IP 2023 Recognizes Goodwin Lawyers and Practices for Excellence in Intellectual Property

Patent Prosecution & Counseling